GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,807,739 | +19.0% | 79,607 | +28.2% | 0.09% | +12.7% |
| Q2 2023 | $2,359,889 | +33.4% | 62,086 | +32.5% | 0.08% | +17.9% |
| Q1 2023 | $1,769,132 | +60.5% | 46,852 | +80.1% | 0.07% | +42.6% |
| Q4 2022 | $1,102,558 | +13.0% | 26,016 | -14.3% | 0.05% | +2.2% |
| Q3 2022 | $976,000 | +15.2% | 30,366 | +16.5% | 0.05% | +21.1% |
| Q2 2022 | $847,000 | +313.2% | 26,061 | +359.7% | 0.04% | +322.2% |
| Q1 2022 | $205,000 | -11.3% | 5,669 | -2.9% | 0.01% | -10.0% |
| Q4 2021 | $231,000 | -12.2% | 5,841 | -3.0% | 0.01% | -37.5% |
| Q3 2021 | $263,000 | +22.9% | 6,024 | +14.8% | 0.02% | 0.0% |
| Q2 2021 | $214,000 | – | 5,246 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |